APA Alıntı

Affronti, M. L., Friedman, H. S., Desjardins, A., Vlahovic, G., Randazzo, D. M., Herndon, J. E., . . . Peters, K. B. (2015). ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG). Neuro Oncol.

Chicago Stili Alıntı

Affronti, Mary L., et al. "ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)." Neuro Oncol 2015.

MLA Alıntı

Affronti, Mary L., et al. "ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)." Neuro Oncol 2015.